- Hutton D, So SKS, Brandeau M. Cost-Effectiveness of Nationwide Hepatitis B Catch-up Vaccination Among Children and Adolescents in China. Hepatology. 6 August 2009. Preprint.
- Wei W, Chua M-S, Grepper S, So SKS. Blockade of Wnt-1 signaling leads to anti-tumor effects in hepatocellular carcinoma cells. Molecular Cancer 2009, 8:76. Article (PDF).
- Lin S, Chang E, So SKS. Stopping a Silent Killer in the Underserved Asian and Pacific Islander Community: A Chronic Hepatitis B and Liver Cancer Prevention Clinic by Medical Students. Asian Pacific J Cancer Prev, 10, 383-386. Article (PDF).
- Chao SD, Chang ET, So SKS. Eliminating the threat of chronic hepatitis B in the Asian and Pacific Islander community: a call to action. Asian Pacific Journal for Cancer Prevention, July 2009. Article (PDF).
- Wei W, Chua M-S, Grepper S, So SKS. Small molecule antagonists of Tcf4/beta-catenin complex inhibit the growth of HCC cells in vitro and in vivo. International Journal of Cancer. Volume 9999 Issue 999A, Published Online: 6 Aug 2009. Article.
- Chang ET, Sue E, Zola J, Lin SY, So SKS. 3 for Life: a model pilot program to prevent hepatitis B and liver cancer in Asian and Pacific Islander Americans. Am J Health Promot, 2009. Article.
- Chang ET, Nguyen BH, So SKS. Attitude towards hepatitis B and liver cancer prevention among Chinese Americans in the San Francisco Bay Area, California. Asian Pacific J Cancer Prev, 9:1-8, 2008. Article.
- Yan X, Chua M-S, He J, So SKS. Small interfering RNA targeting CDC25B inhibits liver tumor growth in vitro and in vivo. Molecular Cancer, 2008 Feb 2. Abstract.
- Yan X, Chua M-S, Sun H, So SKS. N-Myc down-regulated gene 1 mediates proliferation, invasion, and apoptosis of hepatocellular carcinoma cells. Cancer Letter, 2008. Abstract.
- Sun H, Chua M-S, Yang D, Tsalenko , Peter BJ, So SKS. Antibody arrays identify potential diagnostic markers of hepatocellular carcinoma. Biomarker Insights 3:1-18, 2008. Article.
- Lin AY, Fisher GA, So S, Tang C, Levitt L. Phase II study of imatinib in unresectable hepatocellular carcinoma. Am J Clin Oncol 31:84-88, 2008. Abstract.
- Chang ET, Lin SY, Sue E, Bergin M, Su J, So SK. Building partnerships with traditional chinese medicine practitioners to increase hepatitis B awareness and prevention. J Altern Complement Med. 2007 Dec;13(10):1125-7. Article.
- Chao SD, Chang ET, Le PV, Prapong W, Kiernan M, So SK. The Jade Ribbon Campaign: A Model Program for Community Outreach and Education to Prevent Liver Cancer in Asian Americans. J Immigr Minor Health. 2007 Nov 8. Article.
- Gomez SL, Clarke CA, Chang ET, Keegan THM, West DW, So S, Glaser SL. Letter to the editor. Response to McCracken et al.: Cancer surveillance among Asian Americans. CA: A Cancer Journal for Clinicians, eLetter to the editor, Aug 28, 2007. Online Article.
- Wu CA, Lin SY, So SK, Chang ET. Hepatitis B and Liver Cancer Knowledge and Preventive Practices among Asian Americans in the San Francisco Bay Area, California. Asian Pac J Cancer Prev 2007 Jan-Mar; 8: 1: 127-34: Abstract.
- Chua MS, Sun H, Cheung ST, Mason V, Higgins J, Ross DT, Fan ST, So S. Overexpression of NDRG1 is an indicator of poor prognosis in hepatocellular carcinoma. Mod Pathol 2007; 20: 1: 76-83. Abstract.
- Lin SY, Chang ET, So SK. Why we should routinely screen Asian American adults for hepatitis B: A cross-sectional study of Asians in California. Hepatology 2007. Article.
- Hutton DW, Tan D, So SK, Brandeau ML. Cost-effectiveness of screening and vaccinating Asian and Pacific Islander adults for hepatitis B. Ann Intern Med. 2007 Oct 2;147(7):460-9. Article.
- Chang ET, Keegan TH, Gomez SL, Le GM, Clarke CA, So SK, Glaser SL. The burden of liver cancer in Asians and Pacific Islanders in the Greater San Francisco Bay Area, 1990 through 2004. Cancer 2007. Article.
- Chang ET, So SK. Re: ten largest racial and ethnic health disparities in the United States based on healthy people 2010 objectives. Am J Epidemiol 2007; 166: 9: 1105-6. Article.
- Chua MS, Bernstein LR, Li R, So SK. Gallium maltolate is a promising chemotherapeutic agent for the treatment of hepatocellular carcinoma. Anticancer Res 2006 May-Jun; 26: 3A: 1739-43: Abstract.
- Aggarwal A, Li Guo D, Hoshida Y, Tsan Yuen S, Chu KM, So S, Boussioutas A, Chen X, Bowtell D, Aburatani H, Leung SY, Tan P. Topological and functional discovery in a gene coexpression meta-network of gastric cancer. Cancer Res 2006; 66: 1: 232-41: Article.
- Leung YL, Ho C, Tu I-P, Li R, So S, Chu K-M, Yuen ST, Chen X. Comprehensive analysis of 19q12 amplicon in human gastric cancers. Mod Pathol: 19,854-63, 2006. Article.
- Chua MS, Bernstein LR, Li R, So S. Gallium maltolate is a promising chemotherapeutic agent for the treatment of hepatocellular carcinoma. Anticancer Res 2006; May-Jun;26(3A):1739-43. Abstract.
- Fong CW, Chua MS, McKie AB, Ling SH, Mason V, Li R, Yusoff P, Lo TL, Leung HY, So S, Guy GR. Sprouty 2, an inhibitor of mitogen-activated protein kinase signaling, is down-regulated in hepatocellular carcinoma. Cancer Res 2006 Feb 15;66(4):2048-58. Article.
- Cheung ST, Ho JC, Leung KL, Chen X, Fong DY, So S, Fan ST. Transcript AA454543 is a novel prognostic marker for hepatocellular carcinoma after curative partial hepatectomy. Neoplasia 2005; 7: 2: 91-8: Abstract.
- Li VS, Wong CW, Chan TL, Chan AS, Zhao W, Chu KM, So S, Chen X, Yuen ST, Leung SY. Mutations of PIK3CA in gastric adenocarcinoma. BMC Cancer 2005; 5: 1: 29: Abstract.
- Patil MA, Chua MS, Pan KH, Lin R, Lih CJ, Cheung ST, Ho C, Li R, Fan ST, Cohen SN, Chen X, So S. An integrated data analysis approach to characterize genes highly expressed in hepatocellular carcinoma. Oncogene 2005; 24: 23: 3737-47: Article.
- Patil MA, Gütgemann I, Zhang J, Ho C, Cheung ST, Ginzinger D, Li R, Dykema KJ, So S, Fan ST, Kakar S, Furge KA, Büttner R, Chen X. Array-based comparative genomic hybridization reveals recurrent chromosomal aberrations and JAB1 as a potential target for 8q gain in hepatocellular carcinoma. Carcinogenesis 2005; Abstract.
- Cheung ST, Leung KL, Ip YC, Chen X, Fong DY, Ng IO, Fan ST, So S. Claudin-10 expression level is associated with recurrence of primary hepatocellular carcinoma. Clin Cancer Res 2005; 11: 2 Pt 1: 551-6: Abstract.
- Lin AY, Brophy N, Fisher GA, So S, Biggs C, Yock TI, Levitt L. Phase II study of thalidomide in patients with unresectable hepatocellular carcinoma. Cancer 2005; 103: 1: 119-25: Abstract.
- Cheung ST, Wong SY, Leung KL, Chen X, So S, Ng IO, Fan ST. Granulin-epithelin precursor overexpression promotes growth and invasion of hepatocellular carcinoma. Clin Cancer Res 2004; 10: 22: 7629-36: Abstract.
- Leung SY, Yuen ST, Chu KM, Mathy JA, Li R, Chan AS, Law S, Wong J, Chen X, So S. Expression profiling identifies chemokine (C-C motif) ligand 18 as an independent prognostic indicator in gastric cancer. Gastroenterology 2004; 127: 2: 457-69: More
- Cheung ST, Wong SY, Leung KL, Chen X, So S, Ng IO, Fan ST. Granulin-epithelin precursor overexpression promotes growth and invasion of hepatocellular carcinoma. Clin Cancer Res 2004; 10: 22: 7629-36: Abstract,
- Chen X, Higgins J, Cheung ST, Li R, Mason V, Montgomery K, Fan ST, van de Rijn M, So S. Novel endothelial cell markers in hepatocellular carcinoma. Mod Pathol 2004; 17: 10: 1198-210: Abstract.
- Millan MT, Berquist WE, So SK, Sarwal MM, Wayman KI, Cox KL, Filler G, Salvatierra O, Esquivel CO. One hundred percent patient and kidney allograft survival with simultaneous liver and kidney transplantation in infants with primary hyperoxaluria: a single-center experience. Transplantation 2003; 76: 10: 1458-63: Abstract.
- Chen X, Leung SY, Yuen ST, Chu KM, Ji J, Li R, Chan AS, Law S, Troyanskaya OG, Wong J, So S, Botstein D, Brown PO. Variation in gene expression patterns in human gastric cancers. Mol Biol Cell 2003; 14: 8: 3208-15: Abstract.
- Chan AS, Tsui WY, Chen X, Chu KM, Chan TL, Chan AS, Li R, So S, Yuen ST, Leung SY. Downregulation of ID4 by promoter hypermethylation in gastric adenocarcinoma. Oncogene 2003; 22: 44: 6946-53: Abstract.
- Kim P, Prapong W, Sze DY, So SK, Razavi MK. Treatment of hepatocellular carcinoma with sub-selective transcatheter arterial oily chemoinfusion. Tech Vasc Interv Radiol 2002; 5: 3: 127-31: Abstract.
- Chen X, Cheung ST, So S, Fan ST, Barry C, Higgins J, Lai KM, Ji J, Dudoit S, Ng IO, Van De Rijn M, Botstein D, Brown PO. Gene expression patterns in human liver cancers. Mol Biol Cell 2002; 13: 6: 1929-39: Abstract.
- Millan MT, Natkunam Y, Clarke-Katzenberg R, Desai D, Prapong W, So SK, Esquivel CO, Sibley R, Ferran C, Martinez OM. Epstein-Barr virus infection is associated with endothelial Bcl-2 expression in transplant liver allografts. Transplantation 2002; 73: 3: 465-9: Abstract.
- Leung SY, Chen X, Chu KM, Yuen ST, Mathy J, Ji J, Chan AS, Li R, Law S, Troyanskaya OG, Tu IP, Wong J, So S, Botstein D, Brown PO. Phospholipase A2 group IIA expression in gastric adenocarcinoma is associated with prolonged survival and less frequent metastasis. Proc Natl Acad Sci U S A 2002; 99: 25: 16203-8: Abstract.
- Zhang J, Wang Y, Shou C, Xu G, Chen X, Wu J, Xie Y, Li J, So S, Jiafu J. [Detection of Mycoplasma hyorhinis in gastric cancer using bio-chip technology]. Zhonghua Yi Xue Za Zhi 2002; 82: 14: 961-5: Abstract.
- Cheung ST, Chen X, Guan XY, Wong SY, Tai LS, Ng IO, So S, Fan ST. Identify metastasis-associated genes in hepatocellular carcinoma through clonality delineation for multinodular tumor. Cancer Res 2002; 62: 16: 4711-21: Abstract.
- Ji J, Chen X, Leung SY, Chi JT, Chu KM, Yuen ST, Li R, Chan AS, Li J, Dunphy N, So S. Comprehensive analysis of the gene expression profiles in human gastric cancer cell lines. Oncogene 2002; 21: 42: 6549-56: Abstract.
- Lai KM, Millan M, Razavi M, Keeffe EB, Prapong W, Fisher GA, Esquivel CO, So SK. Center experience in liver transplantation for hepatocellular carcinoma associated with cirrhosis. Transplant Proc 2001 Feb-Mar; 33: 1-2: 1490-1: Abstract.
- So S. CMV and EBV-PTLD after liver transplantation. Transplant Proc 2001 Feb-Mar; 33: 1-2: 1317-9: Abstract.
- Sze DY, Razavi MK, So SK, Jeffrey RB. Impact of multidetector CT hepatic arteriography on the planning of chemoembolization treatment of hepatocellular carcinoma. AJR Am J Roentgenol 2001; 177: 6: 1339-45: Abstract.
- Millan MT, Sarwal MM, Lemley KV, Yorgin P, Orlandi P, So S, Alexander S, Salvatierra O. A 100% 2-year graft survival can be attained in high-risk 15-kg or smaller infant recipients of kidney allografts. Arch Surg 2000; 135: 9: 1063-8; discussion 1068-9: Abstract.
- Shetty AK, Gans HA, So S, Millan MT, Arvin AM, Gutierrez KM. Intravenous ribavirin therapy for adenovirus pneumonia. Pediatr Pulmonol 2000; 29: 1: 69-73: Abstract.
- So SK, Esquivel CO, Imperial JC, Garcia G, Monge H, Keeffe EB. Does Asian race affect hepatitis B virus recurrence or survival following liver transplantation for hepatitis B cirrhosis? J Gastroenterol Hepatol 1999; 14 Suppl: S48-52: Abstract.
- So SK, Monge H, Esquivel CO. Major hepatic resection without blood transfusion: experience with total vascular exclusion. J Gastroenterol Hepatol 1999; 14 Suppl: S28-31: Abstract.
- Cacciarelli TV, Keeffe EB, Moore DH, Burns W, Busque S, Concepcion W, So SK, Esquivel CO. Effect of intraoperative blood transfusion on patient outcome in hepatic transplantation. Arch Surg 1999; 134: 1: 25-9: Abstract.
- Cao S, Cox KL, Berquist W, Hayashi M, Concepcion W, Hammes GB, Ojogho OK, So SK, Frerker M, Castillo RO, Monge H, Esquivel CO. Long-term outcomes in pediatric liver recipients: comparison between cyclosporin A and tacrolimus. Pediatr Transplant 1999; 3: 1: 22-6: Abstract.
- Esquivel CO, Keeffe EB, Garcia G, Imperial JC, Millan MT, Monge H, So SK "Resection versus transplantation for hepatocellular carcinoma." J Gastroenterol Hepatol 1999; 14 Suppl: S37-41: Abstract.
- Millan MT, Keeffe EB, Berquist WE, Castillo RO, Cox KL, Garcia G, Imperial JC, Monge H, So SK, Esquivel CO. Liver transplantation at Stanford University Medical Center. Clin Transpl 1998; 287-96: Abstract.
- Cao S, Cox KL, Berquist W, So S, Concepcion W, Monge H, Esquivel CO. Increased dosage requirement and rejection after Neoral conversion in pediatric liver transplant patients. Transplant Proc 1998; 30: 8: 4322-4: Abstract.
- Hayashi M, Keeffe EB, Krams SM, Martinez OM, Ojogho ON, So SK, Garcia G, Imperial JC, Esquivel CO. Allograft rejection after liver transplantation for autoimmune liver diseases. Liver Transpl Surg 1998; 4: 3: 208-14: Abstract.
- Woodle ES, Millis JM, So SK, McDiarmid SV, Busuttil RW, Esquivel CO, Whitington PF, Thistlethwaite JR. Liver transplantation in the first three months of life. Transplantation 1998; 66: 5: 606-9: Abstract.
- Cao S, Cox K, Esquivel CO, Berquist W, Concepcion W, Ojogho O, Monge H, Krams S, Martinez O, So S. Posttransplant lymphoproliferative disorders and gastrointestinal manifestations of Epstein-Barr virus infection in children following liver transplantation. Transplantation 1998; 66: 7: 851-6: Abstract.
- Lucey MR, Brown KA, Everson GT, Fung JJ, Gish R, Keefe EB, Kneteman NM, Lake JR, Martin P, Rakela J, Shiffman ML, So S, Wiesner RH. Minimal criteria for placement of adults on the liver transplant waiting list: a report of a national conference organized by the American Society of Transplant Physicians and the American Association for the Study of Liver Diseases. Transplantation 1998; 66: 7: 956-62: Abstract.
- McDiarmid SV, Millis MJ, Olthoff KM, So SK. Indications for pediatric liver transplantation. Pediatr Transplant 1998; 2: 2: 106-16: Abstract.
- Busque S, Esquivel CO, Concepcion W, So SK. Experience with the piggyback technique without caval occlusion in adult orthotopic liver transplantation. Transplantation 1998; 65: 1: 77-82:
Last Updated: October 1, 2009
